Literature DB >> 25261015

Glutathione-mediated effects of lithium in decreasing protein oxidation induced by mitochondrial complex I dysfunction.

Camila Nascimento1, Helena Kyunghee Kim, L Trevor Young, Karina Martinez Mendonça, Lea Tenenholz Grinberg, Beny Lafer, Ana Cristina Andreazza.   

Abstract

The aim of this study was to elucidate whether glutathione is involved in lithium's ability to decrease carbonylation and nitration produced by complex I inhibition, which is consistently found in BD. Neuroblastoma cells were treated with rotenone, a complex I inhibitor. Our results suggest that glutathione is essential for lithium's ability to ameliorate rotenone-induced protein carbonylation, but not nitration.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25261015     DOI: 10.1007/s00702-014-1318-8

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  28 in total

1.  Glutathione metabolism and oxidative stress in neurodegeneration

Authors: 
Journal:  Eur J Biochem       Date:  2000-08

2.  Rotenone induces apoptosis via activation of bad in human dopaminergic SH-SY5Y cells.

Authors:  Masahiko Watabe; Toshio Nakaki
Journal:  J Pharmacol Exp Ther       Date:  2004-07-27       Impact factor: 4.030

Review 3.  Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling.

Authors:  Paul D Ray; Bo-Wen Huang; Yoshiaki Tsuji
Journal:  Cell Signal       Date:  2012-01-20       Impact factor: 4.315

4.  Long-term exposure to low lithium concentrations stimulates proliferation, modifies stress protein expression pattern and enhances resistance to oxidative stress in SH-SY5Y cells.

Authors:  M S Allagui; R Nciri; M F Rouhaud; J C Murat; A El Feki; F Croute; C Vincent
Journal:  Neurochem Res       Date:  2008-08-08       Impact factor: 3.996

5.  Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder.

Authors:  Ana C Andreazza; Li Shao; Jun-Feng Wang; L Trevor Young
Journal:  Arch Gen Psychiatry       Date:  2010-04

Review 6.  Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.

Authors:  B Halliwell
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

7.  Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate.

Authors:  J Cui; L Shao; L T Young; J-F Wang
Journal:  Neuroscience       Date:  2006-12-19       Impact factor: 3.590

8.  Mitochondrial complex I inhibitor rotenone-elicited dopamine redistribution from vesicles to cytosol in human dopaminergic SH-SY5Y cells.

Authors:  Masahiko Watabe; Toshio Nakaki
Journal:  J Pharmacol Exp Ther       Date:  2007-08-28       Impact factor: 4.030

9.  Molecular evidence for mitochondrial dysfunction in bipolar disorder.

Authors:  Christine Konradi; Molly Eaton; Matthew L MacDonald; John Walsh; Francine M Benes; Stephan Heckers
Journal:  Arch Gen Psychiatry       Date:  2004-03

10.  Decreased global methylation in patients with bipolar disorder who respond to lithium.

Authors:  Aya A Huzayyin; Ana C Andreazza; Gustavo Turecki; Cristiana Cruceanu; Guy A Rouleau; Martin Alda; L Trevor Young
Journal:  Int J Neuropsychopharmacol       Date:  2013-12-17       Impact factor: 5.176

View more
  2 in total

1.  GBR 12909 administration as an animal model of bipolar mania: time course of behavioral, brain oxidative alterations and effect of mood stabilizing drugs.

Authors:  Ana Isabelle G Queiroz; Maíra Moraes de Araújo; Tatiane da Silva Araújo; Greicy Coelho de Souza; Lígia Menezes Cavalcante; Michel de Jesus Souza Machado; David Freitas de Lucena; João Quevedo; Danielle Macêdo
Journal:  Metab Brain Dis       Date:  2015-06-16       Impact factor: 3.584

2.  Mitochondrial dysfunction and lipid peroxidation in rat frontal cortex by chronic NMDA administration can be partially prevented by lithium treatment.

Authors:  Helena K Kim; Cameron Isaacs-Trepanier; Nika Elmi; Stanley I Rapoport; Ana C Andreazza
Journal:  J Psychiatr Res       Date:  2016-02-06       Impact factor: 4.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.